NDV HN Antibodies

Santa Cruz Biotechnology offers a broad range of NDV HN monoclonal antibodies, specifically targeting the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV). NDV HN monoclonal antibodies serve as essential research tools in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The NDV HN protein plays a crucial role in the viral life cycle, facilitating the attachment of the virus to host cells and aiding in the release of newly formed virions. Understanding the function of the NDV HN protein is essential for developing effective vaccines and therapeutic strategies against Newcastle disease, which can have significant impacts on poultry health and the agricultural economy. Research focusing on NDV HN protein interactions has revealed important mechanisms in viral entry and spread. Investigating NDV HN protein expression patterns helps identify potential therapeutic targets and vaccine candidates. Advanced characterization of NDV HN protein functionality contributes to understanding viral pathogenesis and host immune responses. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of Newcastle disease virus and developing innovative therapeutic approaches.